J. Dekeyser et al., WHAT INTRACRANIAL TISSUES IN HUMANS CONTAIN SUMATRIPTAN-SENSITIVE SEROTONIN 5-HT1-TYPE RECEPTORS, Neuroscience letters, 164(1-2), 1993, pp. 63-66
We investigated the presence of sumatriptan-sensitive serotonin (5-HT)
(1) receptors in different human tissues by using a radioligand-bindin
g technique with [H-3]5-HT. Sumatriptan displaced [H-3]5-HT from front
al cortical and striatal membranes in a biphasic manner, with a high-a
ffinity site corresponding to binding to the 5-HT1D receptor. In blood
platelet membranes, sumatriptan displaced [H-3]S-HT with a 100-fold l
ower affinity. Sumatriptan failed to displace [H-3]5-HT in membranes f
rom large cerebral arteries, pial vessels, coronary arteries and dura
mater. These findings suggest that either there are no sumatriptan-sen
sitive 5-HT1 receptors on intracranial blood vessels or they are so sm
all in number that they cannot be detected by the radioligand-binding
technique. Other mechanisms, possibly centrally mediated, may be respo
nsible for the antimigraine action of sumatriptan.